Results
44
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
44 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANZA New | SEK 76.20 | 2.3% | -10.6% | SEK 3.3b | SEK 81.88 | PE26.2x | E34.5% | 1.6% | Tech | ||
KEBNI B New | SEK 1.09 | 17.2% | -2.5% | SEK 295.6m | SEK 1.35 | PS2.2x | E112.9% | n/a | Tech | ||
LIAB | SEK 227.00 | -3.2% | 14.4% | SEK 17.5b | SEK 263.67 | PE25.8x | E28.5% | 2.4% | Capital Goods | ||
SUS New | SEK 161.50 | 5.3% | -9.3% | SEK 8.2b | SEK 192.17 | PE42.6x | E36.1% | n/a | Healthcare | ||
NREST | SEK 106.80 | -1.8% | n/a | SEK 1.3b | SEK 155.00 | PE11.9x | E20.2% | n/a | Consumer Services | ||
SVED B | SEK 40.80 | -2.6% | 12.6% | SEK 2.2b | SEK 53.50 | PE16.9x | E23.0% | 2.5% | Capital Goods | ||
EQL | SEK 79.80 | -4.3% | 140.4% | SEK 2.3b | SEK 65.00 | PE74.4x | E53.3% | n/a | Healthcare | ||
BMAX | SEK 45.34 | -5.0% | 20.1% | SEK 2.7b | SEK 48.00 | PE80.5x | E79.6% | 1.1% | Retail | ||
NWG | SEK 183.80 | 4.7% | 12.1% | SEK 4.4b | SEK 168.25 | PE21.9x | E23.6% | 2.7% | Capital Goods | ||
VERT B | SEK 53.40 | -3.6% | 122.5% | SEK 1.4b | SEK 61.00 | PE40.1x | E44.4% | 0% | Software | ||
FAG | SEK 53.60 | -4.6% | -16.5% | SEK 9.5b | SEK 72.00 | PE23.1x | E24.4% | 3.4% | Capital Goods | ||
SVED BTA B | SEK 36.30 | 2.8% | n/a | SEK 1.9b | n/a | PE13.8x | E24.9% | n/a | Capital Goods | ||
MNTC | SEK 25.00 | -4.2% | -44.1% | SEK 639.2m | SEK 42.67 | PS2.3x | E116.7% | 0% | Healthcare | ||
TRUE B | SEK 50.25 | -5.5% | 45.6% | SEK 17.2b | SEK 63.17 | PE35.2x | E23.6% | 0.8% | Software | ||
IAR B | SEK 123.50 | -13.6% | -1.0% | SEK 1.6b | SEK 200.00 | PS3.1x | E63.5% | 1.2% | Software | ||
XVIVO | SEK 466.50 | -1.0% | 46.7% | SEK 14.7b | SEK 538.17 | PE71.9x | E23.0% | n/a | Healthcare | ||
SINCH | SEK 20.06 | -5.3% | -44.2% | SEK 16.9b | SEK 32.50 | PS0.6x | E93.9% | n/a | Software | ||
BIOA B New | SEK 212.80 | 23.9% | -21.2% | SEK 18.8b | SEK 322.00 | PS112.5x | E62.5% | 0% | Pharmaceuticals & Biotech | ||
NORVA | SEK 27.35 | -5.4% | 14.2% | SEK 5.0b | SEK 35.40 | PE26.4x | E21.2% | n/a | Commercial Services | ||
AVEN | SEK 8.06 | 0.7% | -13.3% | SEK 299.2m | SEK 14.00 | PE18.2x | E22.9% | 0% | Software | ||
TFBANK | SEK 370.00 | 1.6% | 124.2% | SEK 8.0b | SEK 405.00 | PB3.2x | E27.1% | n/a | Banks | ||
MAVEN | SEK 10.35 | 7.1% | -22.5% | SEK 537.2m | SEK 13.00 | PE30.3x | E31.8% | 1.0% | Tech | ||
NETI B | SEK 7.33 | -2.5% | 41.2% | SEK 2.5b | SEK 8.25 | PE29.9x | E22.5% | n/a | Tech | ||
BACTI B | SEK 37.70 | 12.2% | -39.4% | SEK 1.3b | SEK 55.00 | PS5.6x | E100.0% | n/a | Healthcare |